Supernus Pharmaceuticals
SUPN
SUPN
274 hedge funds and large institutions have $1.67B invested in Supernus Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 103 increasing their positions, 91 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
33% less call options, than puts
Call options by funds: $7.41M | Put options by funds: $11.1M
36% less capital invested
Capital invested by funds: $2.6B → $1.67B (-$929M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
274
Holding in Top 10
1
Calls
$7.41M
Puts
$11.1M
Top Buyers
| 1 | +$13.9M | |
| 2 | +$10.9M | |
| 3 | +$9.13M | |
| 4 |
WG
Winton Group
London,
United Kingdom
|
+$8.74M |
| 5 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$7.79M |
Top Sellers
| 1 | -$23M | |
| 2 | -$16.7M | |
| 3 | -$9.6M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$6.55M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$6.08M |